Location History:
- Forsyth, NC (US) (1996)
- Winston-Salem, NC (US) (1998 - 2001)
Company Filing History:
4 out of 507 
3 out of 1,567 
1 out of 832,843 Years Active: 1996-2001
Title: Scott A Washburn: Innovator in Atherosclerosis Research
Introduction
Scott A Washburn is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of medical research, particularly in understanding the effects of certain compounds on cardiovascular health. With a total of 5 patents, his work has implications for both male and female health.
Latest Patents
One of his latest patents focuses on the effects of 17 &agr;-dihydroequilenin on plasma lipid and lipoprotein levels, glucose, insulin concentrations, and coronary artery function. This invention presents a method for using 17 &agr;-dihydroequilenin and its metabolic conjugates to prevent and reduce atherogenesis in both genders. The research indicates that this compound can prevent endothelium-dependent vasoconstriction in males and ovariectomized females. Additionally, it has been shown to increase plasma apolipoprotein A-1 concentrations and lower fasting insulin levels without affecting fasting plasma glucose concentrations. Importantly, 17 &agr;-dihydroequilenin does not exhibit trophic effects on reproductive organs, suggesting its potential for preventing hyperplasia and neoplasia without feminizing effects.
Career Highlights
Throughout his career, Scott A Washburn has worked with reputable organizations, including Wake Forest University and American Home Products Corporation. His research has been pivotal in advancing the understanding of cardiovascular health and the role of specific compounds in mitigating health risks.
Collaborations
He has collaborated with esteemed colleagues such as Thomas B Clarkson and Steven Jay Adelman, contributing to a rich exchange of ideas and research findings in the field.
Conclusion
Scott A Washburn's innovative work in atherosclerosis research highlights the importance of understanding the effects of compounds like 17 &agr;-dihydroequilenin on health. His contributions continue to influence the medical community and pave the way for future advancements in cardiovascular health.